Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.54 |
| ▸ | MEN1 | O00255 | 7/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.54 |
| ▸ | PTPRC | P08575 | 5/20 | 0.54 |
| ▸ | MAOA | P21397 | 5/20 | 0.54 |
| ▸ | NPC1 | O15118 | 5/20 | 0.54 |
| ▸ | HTT | P42858 | 4/20 | 0.54 |
| ▸ | POLB | P06746 | 4/20 | 0.54 |
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | S100A4 | P26447 | 4/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.54 |
| ▸ | RAB9A | P51151 | 4/20 | 0.54 |
| ▸ | APAF1 | O14727 | 3/20 | 0.54 |
| ▸ | GALK1 | P51570 | 3/20 | 0.54 |
| ▸ | BLM | P54132 | 3/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.54 |
| ▸ | TDP2 | O95551 | 2/20 | 0.54 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.54 |
| ▸ | PLCG1 | P19174 | 2/20 | 0.54 |
| ▸ | PPARG | P37231 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30570825 | 0.98 | PTPRC (0.56) | MAPTMEN1KMT2APTPRCMAOA | |
| SCHEMBL2679985 | 0.98 | PTPRC (0.56) | MAPTMEN1KMT2APTPRCMAOA | |
| SCHEMBL357951 | 0.92 | MAPT (0.53) | MAPTMEN1KMT2APTPRCMAOA | |
| SCHEMBL7773334 | 0.91 | PABPC1 (0.47) | MAPTMEN1KMT2APTPRCMAOA | |
| SCHEMBL8956246 | 0.85 | BCL2 (0.51) | MAPTMEN1KMT2APTPRCMAOA | |
| SCHEMBL11781324 | 0.82 | PTPRC (0.40) | MAPTMEN1KMT2APTPRCMAOA | |
| SCHEMBL16491894 | 0.80 | MAPT (0.61) | MAPTMEN1KMT2APTPRCMAOA | |
| SCHEMBL28863786 | 0.80 | PTPRC (0.46) | MAPTMEN1KMT2APTPRCMAOA | |
| SCHEMBL28808731 | 0.80 | ALDH1A1 (0.53) | MAPTMEN1KMT2APTPRCMAOA | |
| SCHEMBL6905740 | 0.80 | MEN1 (0.76) | MAPTMEN1KMT2APTPRCMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110092890-B | Organic conjugated nano poly lattice and preparation method and application thereof | 南京邮电大学 | 2022-09-30 | — | — | CN | claimed |
| CN-114516790-A | Synthesis and luminescence of bis-benzophenanthracenone pentanone discotic liquid crystal compound | 四川师范大学 | 2022-05-20 | — | — | CN | disclosed |
| US-20220002552-A1 | SUBSTITUTED POLYFLUORENE COMPOUNDS | BioLegend, Inc. (US) | 2022-01-06 | — | — | US | disclosed |
| US-11155714-B2 | Substituted polyfluorene compounds | BioLegend, Inc. (US) | 2021-10-26 | — | — | US | disclosed |
| WO-2020226126-A1 | COMPOUND HAVING FLUORENE SKELETON AND METHOD FOR PRODUCING SAME | 帝人株式会社 | 2020-11-12 | — | — | WO | disclosed |
| WO-2020085222-A1 | CRYSTAL OF COMPOUND HAVING FLUORENE SKELETON AND METHOD FOR PRODUCING SAME | 帝人株式会社 | 2020-04-30 | — | — | WO | disclosed |
| US-20190203052-A1 | SUBSTITUTED POLYFLUORENE COMPOUNDS | BIOLEGEND (US) | 2019-07-04 | — | — | US | disclosed |
| EP-3085692-B1 | NOVEL 3,6-DISUBSTITUTED FLUORENE DERIVATIVES | NISSAN CHEMICAL CORP (JP) | 2018-11-21 | — | — | EP | disclosed |
| US-10000694-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2018-06-19 | — | — | US | disclosed |
| WO-2018009861-A1 | SUBSTITUTED POLYFLUORENE COMPOUNDS | BIOLEGEND (US) | 2018-01-11 | — | — | WO | disclosed |
| EP-1284258-B1 | Mono-, oligo- and polyalkylidenefluorenes and their use as charge transport materials | MERCK PATENT GMBH (DE) | 2006-02-08 | — | — | EP | disclosed |
| WO-2005049548-A1 | CROSSLINKABLE SUBSTITUTED FLUORENE COMPOUNDS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-06-02 | — | — | WO | disclosed |
| US-6805922-B2 | Crosslinked liquid crystalline polymer | MERCK PATENT GMBH (DE) | 2004-10-19 | — | — | US | disclosed |
| EP-1427768-A2 | CONJUGATED POLYMERS CONTAINING SPIROBIFLUORENE UNITS AND THE USE THEREOF | Covion Organic Semiconductors GmbH (DE) | 2004-06-16 | — | — | EP | disclosed |
| US-20030067267-A1 | Mono-, oligo-and polyalkylidenefluorenes and their use as charge transport materials | MERCK PATENT GMBH (DE) | 2003-04-10 | — | — | US | disclosed |
| WO-2003020790-A2 | CONJUGATED POLYMERS CONTAINING SPIROBIFLUORENE UNITS AND THE USE THEREOF | COVION ORGANIC SEMICONDUCTORS GMBH (DE) | 2003-03-13 | — | — | WO | disclosed |
| EP-1284258-A2 | Mono-, oligo- and polyalkylidenefluorenes and their use as charge transport materials | MERCK PATENT GmbH (DE) | 2003-02-19 | — | — | EP | disclosed |
| EP-1053578-B1 | USE OF SPIRO COMPOUNDS AS LASER DYES | COVION ORGANIC SEMICONDUCTORS (DE) | 2002-05-08 | — | — | EP | disclosed |
| EP-1053578-A1 | USE OF SPIRO COMPOUNDS AS LASER DYES | Axiva GmbH (DE) | 2000-11-22 | — | — | EP | disclosed |
| WO-1999040655-A1 | USE OF SPIRO COMPOUNDS AS LASER DYES | AXIVA GMBH (DE) | 1999-08-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10000694-B2 | Materials for organic electroluminescent devices | OR10J3, EPCAM, L1CAM | MAPT 550/4885MEN1 1226/4885KMT2A 1418/4885 |
| US-11155714-B2 | Substituted polyfluorene compounds | PARG, PFAS, PARN | MAPT 1970/4885MEN1 1028/4885KMT2A 3560/4885 |
| US-20220002552-A1 | SUBSTITUTED POLYFLUORENE COMPOUNDS | PARG, PFAS, PARN | MAPT 1970/4885MEN1 1028/4885KMT2A 3560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.